Pinnacle Financial Group, Inc.’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
Other funds holding APRE
ACM
Pinnacle Financial Group, Inc.'s APRE Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Aprea Therapeutics (APRE) in Q3 2026: 2,000 shares worth $1.5K. The stake represents ﹤0.01% of the portfolio and ranks #2037 among its holdings.
27 funds tracked by Wall St. Rank hold APRE as of Q3 2026.
- Pinnacle Financial Group, Inc. held 2,000 shares of Aprea Therapeutics worth $1.5K as of Q3 2026.
- Aprea Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Aprea Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2037 holding.
- 27 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.